U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07822347) titled 'Research on NI-FAPI-04 for the Treatment of Hypoxic and Fibroblast Activation Protein Related Tumors' on Aug. 12.
Brief Summary: Exploring the therapeutic value of a novel dual target molecular probe NI-FAPI-04 PET/CT with hypoxia and fibroblast activation related proteins in fibroblast activation related tumors. This study will lay the foundation for the further application of NI-FAPI-04 in tumor therapy and achieve the integration of molecular targeted probes for diagnosis, treatment, and efficacy monitoring.
Study Start Date: Aug. 15, 2025
Study Type: INTERVENTIONAL
Condition:
Tumor
Intervention:
DRUG: Injection of 177Lu-N...